Forward Pharma FA ApS: Financial statements 2020
CVR: 37281603
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Forward Pharma FA ApS (CVR 37281603) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -19,273 and a net result of DKK -23,032 compared with DKK -34,096 the year before. Equity in the 2020 report amounted to DKK 86,567. The solvency ratio was 12.4%.
- Gross Profit
- DKK -19,273
- Profit/Loss
- DKK -23,032
- Equity
- DKK 86,567
- Total Assets
- DKK 697,220
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -19 t. | -23 t. | 87 t. | - |
| 2019 | - | -31 t. | -34 t. | 10 t. | - |
| 2018 | - | -25 t. | -28 t. | -56 t. | - |
| 2017 | - | -569 t. | -447 t. | -29 t. | - |
| 2016 | - | -2.2 mio. | -1.7 mio. | 419 t. | - |
How creditworthy is Forward Pharma FA ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Forward Pharma FA ApS has published its annual report for 2019. Gross profit came to DKK -30,944, and the net result was DKK -34,096.
About Forward Pharma FA ApS
Forward Pharma FA ApS was a Danish company of the type Anpartsselskab based in København K, founded in 2015 and dissolved in 2023. The company was registered under the industry Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik. In 2022, the company reported a gross profit of DKK -32,125 and a net result of DKK -35,837 compared with DKK -11,447 the year before. Equity in the 2022 report amounted to DKK 39,283.